Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • MJFF's Targeted Social Strategy Accelerates Research Participation

    MJFF's Targeted Social Strategy Accelerates Research Participation

    The success of MJFF's targeted Facebook recruitment program for PPMI was highlighted in the news.
    Learn more
  • Another Leap Forward for LRRK2 Development

    Another Leap Forward for LRRK2 Development

    With confidence from MJFF-led studies, Denali Therapeutics today announced it has licensed LRRK2 inhibitor compounds from Genentech.
    Learn more
  • Reactions to Apple's ResearchKit Announcement Reverberate Around Web

    Reactions to Apple's ResearchKit Announcement Reverberate Around Web

    Following Monday's announcement of Apple's ResearchKit and MJFF's Fox Insight online study, news outlets around the web are chiming in about technology's impact on medical…
    Learn more
  • New Technologies Amplify Parkinson’s Patient Voice in Research

    New Technologies Amplify Parkinson’s Patient Voice in Research

    In conjunction with Apple's announcement of ResearchKit, MJFF is announcing the launch of Fox Insight, a Web-based virtual clinical study open to individuals of any age, both with and without PD.
    Learn more
  • Fox Trial Finder Recruits 40,000 Volunteers

    Fox Trial Finder Recruits 40,000 Volunteers

    The PD community reacts to this incredible accomplishment -- 40,000 registered volunteers have raised their hands to participate in Parkinson's clinical research.
    Learn more
  • Default content image

    MJFF Research Staff Reflects on Some of 2011's Big Impact Projects

    This week, the MJFF research staff reflected on some of the projects they worked on in 2011 that they believe could have the greatest impact on the Parkinson’s disease (PD) patient community. 
    Learn more
  • Default content image

    MJFF Awardee Announces Collaborative Agreement With GlaxoSmithKline

    Today, MJFF awardee ProteoTech, Inc., a privately held biotechnology company, announced a funding agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech’s…
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year